Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer

被引:0
|
作者
Aikawa, H [1 ]
Takahashi, H [1 ]
Fujimura, S [1 ]
Sato, M [1 ]
Endo, C [1 ]
Sakurada, A [1 ]
Kondo, T [1 ]
Tanita, T [1 ]
Matsumura, Y [1 ]
Ono, S [1 ]
Saito, Y [1 ]
Sagawa, M [1 ]
机构
[1] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
angiogenesis; VEGF; PD-ECGF; lung cancer; microvessel density;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. In order to elucidate the roles of tumor angiogenesis in lung carcinogenesis, the expressions of several angiogenic factors in lung carcinoma tissues were examined. Materials and Methods. Tissue specimens from 112 cases of resected non-small cell lung cancel (NSCLC) were studied. The expressions of platelet-derived endothelial cell growth factor (PD-ECGF) and vascular endothelial growth factor (VEGF) were examined immunohistochemically. Microvessel density (MVD) was also evaluated. Results. VEGF-positive cases were observed more frequently in advanced stage lung cancers than in early cancers and VEGF-positive rumors had higher MVD than VEGF-negative tumors, while such differences were not observed for PD-ECGF. In squamous cell carcinoma, the patients with hgh-MVD tumor had significantly worse survival than those with low-MVD tumor. Conclusions. Our results suggest that VEGF plays an important role in angiogenesis of lung cancers, wile the contribution of PD-ECGF may be limited.
引用
收藏
页码:4305 / 4309
页数:5
相关论文
共 50 条
  • [21] Factors Affecting Tumor Recurrence in Early Stage Non-small Cell Lung Cancer
    Duma, Narjust
    Dominguez, Yulanka Castro
    Harper, Harry
    Gutierrez, Martin
    CHEST, 2015, 148 (04)
  • [22] Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
    Stewart, David J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (03) : 173 - 234
  • [23] Anti-angiogenic agents in the treatment of non-small cell lung cancer
    Szyszka-Barth, Katarzyna
    Ramlau, Katarzyna
    Stencel, Dariusz
    Ramlau, Rodryg
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 11 (02) : 145 - 150
  • [24] Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer
    Tian, Wentao
    Cao, Chenghui
    Shu, Long
    Wu, Fang
    ONCOTARGETS AND THERAPY, 2020, 13 : 12113 - 12129
  • [25] Angiogenic markers in breath condensate identify non-small cell lung cancer
    Gessner, C.
    Rechner, B.
    Hammerschmidt, S.
    Kuhn, H.
    Hoheisel, G.
    Sack, U.
    Ruschpler, P.
    Wirtz, H.
    LUNG CANCER, 2010, 68 (02) : 177 - 184
  • [26] Testin is a tumor suppressor in non-small cell lung cancer
    Wang, Ming
    Wang, Qian
    Peng, Wen-Jia
    Hu, Jun-Feng
    Wang, Zu-Yi
    Liu, Hao
    Huang, Li-Nian
    ONCOLOGY REPORTS, 2017, 37 (02) : 1027 - 1035
  • [27] Tumor immunity landscape in non-small cell lung cancer
    Yu, Xiaoqing
    Wang, Xuefeng
    PEERJ, 2018, 6
  • [28] Non-Small Cell Lung Cancer-Tumor Biology
    Rojiani, Mumtaz V.
    Rojiani, Amyn M.
    CANCERS, 2024, 16 (04)
  • [29] Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
    Passalidou, E
    Trivella, M
    Singh, N
    Ferguson, M
    Hu, J
    Cesario, A
    Granone, P
    Nicholson, AG
    Goldstraw, P
    Ratcliffe, C
    Tetlow, M
    Leigh, I
    Harris, AL
    Gatter, KC
    Pezzella, F
    BRITISH JOURNAL OF CANCER, 2002, 86 (02) : 244 - 249
  • [30] Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
    E Passalidou
    M Trivella
    N Singh
    M Ferguson
    J Hu
    A Cesario
    P Granone
    A G Nicholson
    P Goldstraw
    C Ratcliffe
    M Tetlow
    I Leigh
    A L Harris
    K C Gatter
    F Pezzella
    British Journal of Cancer, 2002, 86 : 244 - 249